Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Meningitis, Pediatric


Basics


Description


Inflammation of the membranes of the brain or spinal cord, usually caused by viruses or bacteria and, rarely, fungi or parasites ‚  

Epidemiology


  • Bacterial meningitis
    • Most common agents in children of all ages include Streptococcus pneumoniae and Neisseria meningitidis.
    • Underlying host factors, age, exposure, and geographic location alter incidence and pathogen.
  • Viral meningitis
    • Most common agent in all age groups
    • Most common isolated virus are enteroviruses that tend to occur in outbreaks in summer and early fall.
  • Fungal meningitis
    • Cryptococcus neoformans is a budding encapsulated yeast-like organism found in soil and avian excreta; associated with immunocompromised patients (especially AIDS), rare cases in healthy children
    • Candida species occurs in immunocompromised patients and ill premature infants.
  • Tuberculous meningitis
    • Mycobacterium tuberculosis (TB) meningitis occurs in 0.5% of untreated primary TB infections.
    • Most common in children aged 6 months to 4 years
    • In ’ ˆ Ό50% of cases, miliary TB is accompanied by meningitis.

General Prevention


  • Haemophilus influenzae type b (Hib) vaccine has significantly reduced the incidence of meningitis and other invasive Hib infections by up to 99%.
  • 13-valent S. pneumoniae protein conjugate vaccine (PCV13) for use in all infants given at 2, 4, 6, and 12 " “15 months of age
  • A tetravalent meningococcal vaccine (MCV4) is recommended for all patients ≥11 years of age and select at-risk populations <11 years. A booster dose is recommended for all patients who receive the first dose of the vaccine between 11 and 15 years of age.

Etiology


  • Bacterial
    • Cause differs depending on age:
      • <1 month old: group B Streptococcus, gram-negative pathogens (Escherichia coli, Citrobacter koseri, Cronobacter sakazakii, Serratia marcescens, and Salmonella species), Listeria monocytogenes, S. pneumoniae
      • 1 " “3 months old: group B Streptococcus, E. coli, S. pneumoniae, Hib
      • 3 months to 5 years old: S. pneumoniae, N. meningitidis, Hib
      • >5 years old: S. pneumoniae, N. meningitidis
      • Consider Hib in unvaccinated patients of any age.
  • Viral
    • Herpes simplex virus (HSV) in the neonatal population
    • Enteroviruses: ’ ˆ Ό70 different strains that include polioviruses, coxsackie A, coxsackie B, and echoviruses. Recently discovered enteroviruses are not placed in these 4 groups but are numbered (e.g., enterovirus 68).
    • Other, less common: arboviruses (e.g., West Nile virus), mumps
  • Fungal
    • Fungi most commonly isolated include Candida species, Coccidioides immitis, Cryptococcus neoformans, and Aspergillus species.
  • Aseptic meningitis
    • Agents not easily cultured in the viral or microbiology laboratory can cause meningitis and include Borrelia burgdorferi (Lyme disease) and Treponema pallidum (syphilis).
  • Tuberculous meningitis
  • Unusual pathogens more likely in immunocompromised patients

Diagnosis


  • Age-specific
  • Pain
  • Fever
  • Nausea and/or vomiting

History


  • Bacterial meningitis
    • Older children may complain of classic meningeal inflammation signs including neck pain, headache, or back pain as well as photophobia, anorexia, and myalgias.
    • Nausea and vomiting are common.
    • In younger children, symptoms are often nonspecific, including fever, hypothermia, irritability, and poor feeding as well as signs of increased intracranial pressure, including seizures and apnea.
    • Attention should be noted to the patient 's immunization status, birth history, travel history, trauma, health status, geographic location, and exposure to high-risk contacts.
    • Common chief complaints by the infants ' caregivers include the following:
      • Irritable or "sleeping all the time " 
      • "Won 't take to bottle " 
      • "Not acting right " 
      • "Cries when moved or picked up " 
  • Viral meningitis
    • Headache and fever may precede signs of meningitis, such as stiff neck, vomiting, and photophobia.
    • Duration 2 " “6 days
  • Fungal meningitis
    • Cryptococcal meningitis is often indolent, with complaints of worsening headaches and vomiting for days to weeks.
    • Exposure to pigeon or other bird droppings can be a valuable clue.
  • Tuberculous meningitis
    • Symptoms are often nonspecific initially, with personality changes, fever, nausea, and vomiting progressing to anorexia, irritability, and lethargy (stage I disease).
    • Stage II disease is characterized by focal neurologic signs (most often involving the cranial nerves III, VI, and VII).
    • Stage III disease is characterized by coma and papilledema.

Physical Exam


  • Stiff neck in older children. Infants have poor neck muscle tone and this finding is commonly absent.
  • Brudzinski and Kernig signs may be present.
    • Brudzinski sign: With the patient supine, flexion of the neck elicits involuntary flexion of the hips or knees.
    • Kernig sign: With the patient supine, the legs are flexed 90 degrees at the hip, extensions of the lower legs are unable to be accomplished beyond 135 degrees.
    • Negative Brudzinski or Kernig sign does not rule out meningitis.
  • Younger children may not have nuchal rigidity and Kernig and/or Brudzinski signs.
  • Any infant presenting with a sepsis-like picture needs to have meningitis as a consideration.
  • Classically, there may be "paradoxical "  crying " ”crying that increases when child is picked up.
  • Signs of increased intracranial pressure, including papilledema, asymmetric pupils, bulging fontanelle, diplopia
  • Skin exam for erythema migrans from borreliosis (Lyme disease), petechiae, or purpura with invasive meningococcal disease or vesicles in an infant <6 weeks old with HSV

Diagnostic Tests & Interpretation


Lab
  • CSF analysis (cell count with differential, protein measurement, glucose concentration, and measurement of pressure)
  • CSF gram stain and culture
  • Blood culture
  • CBC, platelet count, electrolytes, BUN, creatinine, serum glucose,
  • Consider prothrombin time (PT), partial thromboplastin time (PTT), liver function tests, arterial blood gas

Diagnostic Procedures/Other
  • Lumbar puncture
    • Contraindicated with cardiopulmonary compromise, uncorrected coagulopathy, signs of increased intracranial pressure, or focal neurologic findings until head imaging can be obtained
  • If no etiology is discovered after the first lumbar puncture and the child is not responding to therapy, repeat lumbar puncture at 36 " “48 hours.
  • Opening pressure: normal is <200 mm H2O in lateral recumbent position
  • Depending on the presentation, age, history, and physical exam findings, some or all of the following tests should be requested for CSF analysis:
    • Cell count with differential and Gram stain
      • Bacterial meningitis is characterized by CSF pleocytosis (>1.0 ƒ — 103/ Ž ΌL) with predominance of neutrophils. Culture is the gold standard for diagnosis.
      • Viral meningitis typically has a lower CSF cell count (0.05 " “0.5 ƒ — 103/ Ž ΌL) compared to bacterial meningitis with a predominance of lymphocytes.
    • Glucose: Compare with serum glucose; normal is >40 mg/dL or 1/2 " “2/3 of the serum glucose.
    • Protein: normal is 5 " “40 mg/dL except in newborns, who may have protein levels of 150 " “200 mg/dL
      • >1.0 g/dL in bacterial meningitis and normal to slightly elevated in viral meningitis
    • Cultures for bacteria, fungi, virus, and mycobacteria
      • 80% of blood cultures are positive in children with bacterial meningitis.
    • Polymerase chain reaction (PCR) analysis for enterovirus, TB, HSV, Epstein-Barr virus
      • B. burgdorferi PCR for CSF samples has a diagnostic yield as low as 17%. Antibody studies for neuroborreliosis are recommended.

Differential Diagnosis


  • Encephalitis
  • Toxic encephalopathy
  • Epidural abscess
  • Cerebral abscess

Treatment


General Measures


  • Ensure adequate ventilation and cardiac function.
    • Circulation, airway, breathing (CABs)
  • Initiate hemodynamic monitoring and support by achieving venous access and treat shock syndrome, if present.
  • Prompt initiation of appropriate antimicrobials
    • If a lumbar puncture cannot be obtained or is contraindicated, a blood culture should be obtained and antimicrobials initiated immediately.
  • Monitor serum sodium concentrations because syndrome of inappropriate ADH secretion (SIADH) is a frequent complication during the first 3 days of treatment.
  • Steroids should be used in the initial therapy of TB meningitis along with anti-TB medication.
  • Steroids are indicated for Hib meningitis and can be considered in S. pneumoniae meningitis; has been shown to decrease hearing loss and neurologic sequelae but not overall mortality. Consult ID expert for use.
    • If giving steroids, use dexamethasone 0.6 mg/kg/24 h divided into 4 doses and given for 4 days. The first dose should be given before or with the first dose of antibiotic.

Medication


  • Antimicrobial agents
    • <1 month of age: ampicillin IV 200 " “300 mg/kg/24 h divided q6 " “12h based on postnatal age and weight. If <7 days of age, 200 mg/kg/24 h divided q8h; if >7 days of age, ampicillin 300 mg/kg/24 h divided q6h and cefotaxime IV 200 " “300 mg/kg/24 h divided q6h
    • >1 month of age: vancomycin IV 60 " “80 mg/kg/24 h divided q6h; cefotaxime IV 300 mg/kg/24 h divided q6h or ceftriaxone 100 mg/kg/24 h divided q12h (should not be used in infants <2 months of age)
    • Vancomycin IV 60 " “80 mg/kg/24 h divided q6h should be considered in a patient of any age suspected of S. pneumoniae.
    • Alternative therapy for penicillin- or cephalosporin-allergic patients can include carbapenem or a quinolone in addition to vancomycin. Infectious disease specialist input should be considered.
  • Fungal meningitis
    • Amphotericin B with or without 5-flucytosine
  • Tuberculous meningitis
    • Treatment is generally with 4 drugs for 2 months followed by 2 drugs for 10 months.
    • Initially, treat with isoniazid, rifampin, pyrazinamide, and streptomycin.
  • Viral meningitis
    • Enterovirus: supportive care
    • HSV: acyclovir 60 mg/kg/24 h IV divided q8h

Alert
  • Remember that in tuberculous meningitis, up to 50% of children will not react to the 5-tuberculin unit Mantoux tests. Therapy should be started if suspicious; do not rely on the skin testing.
  • With the potential for resistant S. pneumoniae, vancomycin and cefotaxime or ceftriaxone should be used until antibiotic susceptibility data are available.

Ongoing Care


Follow-up Recommendations


  • Neonatal HSV meningitis should be evaluated with a repeat CSF HSV DNA PCR at day 21 and therapy extended if the PCR remains positive.
  • Prophylaxis in Hib:
    • Oral rifampin (20 mg/kg/dose, maximum 600 mg/24 h for 4 days) should be given to all household contacts if 1 member is <4 years of age and is unvaccinated.
  • Prophylaxis in N. meningitidis:
    • Oral rifampin (10 mg/kg/dose, maximum 600 mg b.i.d. for 2 days) for all household contacts, day care contacts, and other persons with close contact 7 days prior to onset of illness

Patient Monitoring
  • Most children with bacterial meningitis become afebrile by 7 " “10 days after starting therapy, with gradual improvement in activity with less irritability.
  • Evaluation for neurologic sequelae, such as hearing and vision testing, is essential.

Prognosis


  • Bacterial meningitis
    • Fatality approaches 100% if untreated.
    • ’ ˆ Ό500 " “1,000 deaths each year, or 5 " “10% of cases
    • Hearing deficits and neurologic damage may occur in up to 30% of children.
  • Viral meningitis
    • Prognosis for enteroviral meningitis is good.
  • Aseptic meningitis
    • Lyme disease: Prognosis with diagnosis and treatment is good.
  • Tuberculous meningitis
    • The long-term prognosis in children with tuberculous meningitis depends on the stage of disease in which treatment is begun.
    • Complete recovery occurs in 94% of those whose treatment was started in stage I but only 51% and 18% for those whose treatment began in stage II or stage III, respectively.

Complications


  • Bacterial meningitis
    • Acute complications: SIADH and seizures occur in up to 1/3 of patients, focal neurologic signs occur in 10 " “15%.
    • Long-term complications: neurocognitive defects, hearing defects (most common morbidity among survivors)
  • Viral meningitis
    • Acute complications: SIADH in 10%
    • Long-term complications: Complications from viral meningitis are rare. However, neonates (<1 month of age) may develop severe enterovirus disease and older agammaglobulinemic children may develop chronic enterovirus meningoencephalitis.
  • Tuberculous meningitis
    • Acute complications: most common are cranial nerve findings, especially 6th cranial nerve palsy affecting the eyes; hydrocephalus
    • Long-term complications: many, including blindness, deafness, and mental retardation

Additional Reading


  • Brouwer ‚  MC, McIntyre ‚  P, Prasad ‚  K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev.  2013;6:CD004405. ‚  [View Abstract]
  • Kestenbaum ‚  LA, Ebberson ‚  J, Zorc ‚  JJ, et al. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics.  2010;125(2):257 " “264. ‚  [View Abstract]
  • Maconochie ‚  I, Baumer ‚  H, Stewart ‚  ME. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev.  2008;(1):CD004786. ‚  [View Abstract]
  • Mann ‚  K, Jackson ‚  MA. Meningitis. Pediatr Rev.  2008;29(12):417 " “430. ‚  [View Abstract]

Codes


ICD09


  • 322.9 Meningitis, unspecified
  • 320.9 Meningitis due to unspecified bacterium
  • 047.9 Unspecified viral meningitis
  • 320.2 Streptococcal meningitis
  • 321.0 Cryptococcal meningitis
  • 036.0 Meningococcal meningitis

ICD10


  • G03.9 Meningitis, unspecified
  • G00.9 Bacterial meningitis, unspecified
  • A87.9 Viral meningitis, unspecified
  • G00.2 Streptococcal meningitis
  • B45.1 Cerebral cryptococcosis

SNOMED


  • 7180009 Meningitis (disorder)
  • 95883001 Bacterial meningitis (disorder)
  • 58170007 Viral meningitis (disorder)
  • 4510004 Streptococcal meningitis (disorder)
  • 192644005 Meningococcal meningitis (disorder)
  • 14232007 Cryptococcal meningitis (disorder)

FAQ


  • Q: Is a lumbar puncture required before starting antibiotics in the patient with suspected meningitis with unstable vital signs requiring resuscitation?
  • A: No. In the unstable patient, it is contraindicated to perform a lumbar puncture. Appropriate IV antibiotics should be started. When resuscitated, a lumbar puncture should be performed.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer